NASDAQ: MODDModular Medical Inc Stock
$1.07+0.05 (+4.9%)
Updated Apr 30, 2025
MODD Price
$1.07
Fair Value Price
$0.36
Market Cap
$43.51M
52 Week Low
$0.68
52 Week High
$2.65
P/E
-2.02x
P/B
4.24x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$18.18M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.18
Operating Cash Flow
-$15M
Beta
0.45
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
MODD Overview
Modular Medical Incorporated develops insulin pumps for patients with diabetes. Modular Medical was founded in 1998 and is headquartered in San Diego, CA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine MODD's potential to beat the market
- MODD doesn't meet the minimum data requirements for our proprietary Zen Ratings model. Learn more about Zen Ratings.
Zen Rating Component Grades
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Medical Device
Industry Rating
C
MODD
RankedUnranked of 108
RankedUnranked of 108
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $7.31 | A | |
| $23.03 | A | |
| $14.12 | A |
Be the first to know about important MODD news, forecast changes, insider trades & much more!
MODD News
Overview
Due Diligence Score
–
Industry Average (28)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how MODD scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MODD ($1.07) is overvalued by 197.73% relative to our estimate of its Fair Value price of $0.36 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
MODD ($1.07) is not significantly undervalued (197.73%) relative to our estimate of its Fair Value price of $0.36 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
MODD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more MODD due diligence checks available for Premium users.
Valuation
MODD fair value
Fair Value of MODD stock based on Discounted Cash Flow (DCF)
Price
$1.07
Fair Value
$0.36
Overvalued by
197.73%
MODD ($1.07) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MODD ($1.07) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MODD is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
MODD price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-2.02x
Industry
37.39x
Market
29.18x
MODD price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
4.24x
Industry
3.94x
MODD is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MODD's financial health
Profit margin
Revenue
$0.0
Net Income
-$4.8M
Profit Margin
0%
MODD's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$12.1M
Liabilities
$1.9M
Debt to equity
0.18
MODD's short-term assets ($7.33M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MODD's short-term assets ($7.33M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MODD's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
MODD's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$4.1M
Investing
-$542.0k
Financing
$7.7M
MODD's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
MODD vs Medical Device Stocks
Modular Medical Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.